Chongqing Taiji Industry(Group) Co.,Ltd (SHA:600129)

Market Cap	7.38B -37.7%
Revenue (ttm)	10.20B -7.3%
Net Income	111.65M
EPS	0.21
Shares Out	551.42M
PE Ratio	64.93
Forward PE	26.78
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,108,300
Open	13.02
Previous Close	13.02
Day's Range	12.95 - 13.39
52-Week Range	12.88 - 25.51
Beta	0.23
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHA:600129

Chongqing Taiji Industry(Group) Co.,Ltd, together with its subsidiaries, engages in the production and sales of Chinese and western medicine products in China and internationally. It operates through Pharmaceutical Industry; Pharmaceutical Business; Chinese medicinal materials Resources; Big Health and International; and Service Industry and Others segments. The company offers respiratory system, digestive system and metabolic, nervous system, cardiovascular and cerebrovascular, big health, anti-infective, anti-tumor, immunomodulatory drugs; an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1979
• Employees: 10,864
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600129

Financial Performance

In 2025, SHA:600129's revenue was 10.50 billion, a decrease of -15.23% compared to the previous year's 12.39 billion. Earnings were 120.57 million, an increase of 352.37%.